When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Halozyme Therapeutics (NASDAQ:HALO) has dipped 1.5% postmarket after posting its Q4 report, where revenues and profits trailed expectations though the company reiterated strong guidance and upcoming sustained profitability.
More news on: Halozyme Therapeutics, Inc., Healthcare stocks news, Earnings news and commentary,